Jing-Jin Electric Technologies Co.Ltd(688280) : Jing-Jin Electric Technologies Co.Ltd(688280) special report on the deposit and use of raised funds in 2021

Securities code: Jing-Jin Electric Technologies Co.Ltd(688280) securities abbreviation: Jing-Jin Electric Technologies Co.Ltd(688280) Announcement No.: 2022015 Jing-Jin Electric Technologies Co.Ltd(688280)

Special report on the deposit and actual use of the company’s raised funds

The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.

1、 Basic information of raised funds (I) actual amount of raised funds and time of funds in place

Approved by the reply on Approving the registration of Jing-Jin Electric Technologies Co.Ltd(688280) initial public offering (zjxk [2021] No. 2821) of China Securities Regulatory Commission, the company issued 14755000 ordinary shares (A shares) to domestic investors for the first time, with a par value of RMB 1.00 per share and an increase of registered capital of RMB 1475500000. The issue price per share of this public offering is 13.78 yuan, and the total amount of funds raised is 203330790000 yuan. After deducting the expenses of recommendation and underwriting, audit and capital verification, lawyer fees, information disclosure fees, stamp duty and issuance handling fees, the total amount of 17857097336 yuan, the actual net amount of funds raised is 185473692664 yuan. The above funds were in place on October 21, 2021, and Lixin Certified Public Accountants (special general partnership) verified and issued a capital verification report (xksbz [2021] No. zb11473). The company has adopted special account storage management for the raised funds.

As of December 31, 2021, the company has used the raised funds of RMB 59583234424, and the balance of unused raised funds is RMB 125890458240. The balance of the raised capital account is 126720046391 yuan, and the difference with the unused raised capital balance is 829588151 yuan. The reasons for the difference are as follows: (1) the expenditure amount exceeds 42458235 yuan of the original raised investment project planning; (2) The bank’s net interest income from the raised funds is 224957776 yuan; (3) The outstanding issuance fee is 647088610 yuan. (II) use amount and ending balance of raised funds in the reporting period

As of December 31, 2021, the use and balance of raised funds are as follows:

Project amount (yuan)

Total raised funds 203330790000

Less: paid issuance related expenses 17210008726

Less: taxes related to issuance expenses-

Minus: 59583234425 yuan paid by the special account of raised funds for the investment amount of the raised investment project

Less: handling fee expense 207.12

Less: temporarily idle raised funds for cash management investment-

Plus: income from temporarily idle raised funds for cash management and financial management-

Plus: interest income 224978488

Less: others (amount exceeding the standard used up to 1231) 42458234

As of December 31, 2021, the balance of the special account for raised funds was 126720046391

2、 Management of raised funds (I) management of raised funds

In order to standardize the management and use of raised funds and protect the rights and interests of investors, the company has formulated the management system of raised funds of the company (hereinafter referred to as the management system) in accordance with the provisions of the measures for the management of raised funds of listed companies on Shanghai Stock Exchange and other documents, and in combination with the actual situation of the company, which has made specific and clear provisions on the storage, use and supervision of the use of raised funds of the company, And deposit, use and manage funds in accordance with the provisions of the management system.

In October 2021, the company signed the tripartite supervision agreement on the special account storage of raised funds with the sponsor Huatai United Securities Co., Ltd. and the commercial bank with the special account for the storage of raised funds. The company, the company’s subsidiary Jing-Jin Electric Technologies Co.Ltd(688280) Technology (Heze) Co., Ltd Jingjin best electric (Shanghai) Co., Ltd. has signed the four party supervision agreement on the special account for the storage of raised funds with the sponsor Huatai United Securities Co., Ltd. and the commercial bank with a special account for the storage of raised funds to strictly approve the use of raised funds, so as to ensure the special use of funds. As of December 31, 2021, the company has deposited and used the raised funds in strict accordance with the provisions of the tripartite supervision agreement on raised funds or the Quartet supervision agreement on raised funds. (II) storage of raised funds in the special account as of December 31, 2021, the specific storage of raised funds is as follows:

Deposit bank account number deposit method account balance

Bank Of Hangzhou Co.Ltd(600926) Beijing Branch Sales Department 11010401600001341311 current 37815706284

Beijing Beijing Centergate Technologies (Holding) Co.Ltd(000931) bank 10058900050 Yanan Bicon Pharmaceutical Listed Company(002411) 7 current 4238713204

Beijing Beijing Centergate Technologies (Holding) Co.Ltd(000931) bank 10058900050 Aishida Co.Ltd(002403) 3 current 2438501581

China Merchants Bank Co.Ltd(600036) Beijing Dongfang Plaza sub branch 110908904910868 current 4142941265

Bank Of Shanghai Co.Ltd(601229) Beijing Rongxin sub branch 0 Trust Alliance Information Development Inc.Ltd.Shanghai(300469) 6076 current 9468613647

China Merchants Bank Co.Ltd(600036) Shanghai xinkezhan sub branch 110908904910118 current 21327015216

China Merchants Bank Co.Ltd(600036) Beijing Dongfang Plaza sub branch 110908904910899 current 4730815917

Industrial Bank Co.Ltd(601166) Beijing Dongsi sub branch 3213401 Zhejiang Hisoar Pharmaceutical Co.Ltd(002099) 51 current 42557739277

Total — 126720046391

3、 Actual use of raised funds in this year (I) use of funds for investment projects with raised funds

As of December 31, 2021, the raised funds actually invested by the company in relevant projects amounted to RMB 595832300. See “Schedule 1: comparison table of the use of raised funds in 2021” for the specific use.

”(II) early investment and replacement of raised investment projects

As of October 31, 2021, the investment projects invested by the company with self raised funds in advance are as follows:

Unit: RMB

S / n project name self raised fund advance investment amount

1. 9608366588 core upgrading project in R & D, design, process development and test of high and medium end electric drive system

2 new generation electric drive system industrialization upgrading project 3654407473

3 information system construction and upgrading project 488240857

Total 13751014918

As of October 31, 2021, the company has paid 647088610 yuan (excluding value-added tax) for the issuance expenses with its own funds. The details are as follows:

Unit: RMB

S / N expense item self raised funds pre invested amount

1. Audit fee and verification fee 335000000

2. Attorney fee: 140000000

3. Other issuance expenses 172088610

Total 647088610

On February 21, 2022, the 18th meeting of the second board of directors and the 7th Meeting of the second board of supervisors deliberated and approved the proposal on using raised funds to replace self raised funds invested in pre raised projects and paid issuance expenses, and agreed that the company should use raised funds to replace self raised funds invested in pre raised projects and paid issuance expenses, with a total replacement fund of 14398103528 yuan. The replacement time of the raised funds is less than 6 months from the arrival date of the raised funds, which meets the requirements of relevant laws and regulations. The above matters are within the approval authority of the board of directors and do not need to be submitted to the general meeting of shareholders for deliberation. The independent directors of the company also expressed clear consent.

As of December 31, 2021, the company has not used the raised funds to replace the self raised funds invested in advance, so it is not included in the investment of this year. (III) temporary replenishment of working capital with idle raised funds

During the reporting period, the company did not temporarily supplement working capital with idle raised funds. (IV) cash management of idle raised funds and investment in related products

During the reporting period, the company did not use idle raised funds for cash management and investment in related products. (V) permanent replenishment of working capital or repayment of bank loans with over raised funds

During the reporting period, the company did not permanently supplement working capital or repay bank loans with over raised funds. (VI) use of over raised funds for projects under construction and new projects (including acquisition of assets, etc.)

During the reporting period, the company did not use the over raised funds for projects under construction and new projects (including the acquisition of assets, etc.). (VII) use of surplus raised funds

Since the implementation of the raised investment project has not been completed, the company did not use the surplus raised funds during the reporting period. (VIII) other information about the use of raised funds

In the prospectus of the initial public offering of shares, the company disclosed that the “R & D and design, process development and test center upgrading project of high and middle end electric drive system” plans to use the raised funds of 470 million yuan, including 15 million yuan for sample trial production and test costs. Before the funds raised in this offering are in place, the company has invested self raised funds in the pilot test of “high and medium end electric drive system R & D and design, process development and test center upgrading project”

Manufacturing and testing costs 15 million yuan; As of December 31, 2021, the company has invested 40900 yuan in sample trial production and test with raised funds, and the actual expenditure on sample trial production and test is 154099 million yuan, which exceeds the planning of the original raised investment project by 40900 yuan. In addition, RMB 37000 will be paid when the R & D center and the test drive system are upgraded. The use of the above raised funds exceeded the planning and tax payment of the original raised investment project by a total of 424600 yuan.

For the above matters, the company takes the following corrective measures:

From February to April 2022, the company paid 424600 yuan for the use of raised funds exceeding the original raised investment project planning and tax payment, of which 408200 yuan was returned by the counterparty to the company’s special account for raised funds, and the remaining 16400 yuan could not be returned by the counterparty in time due to the impact of the epidemic, so it was returned from the company’s own fund account to the special account for raised funds. As of the issuance date of this special report, the amount of expenditure exceeding 424600 yuan planned for the original raised investment project has been returned to the special account for raised funds of the company.

After the occurrence of the above events, the recommendation institution requires the company to strengthen the study and implementation of the management measures for raised funds, and the recommendation agent

- Advertisment -